Feed aggregator

ChrisHartman: NeoProfen (ibuprofen lysine) Injection: Recall and Shortage - Risk of Particulate Matter http://bit.ly/9IPiDX

Potential for particulate matter to result in serious adverse effects.

FDA is cautioning healthcare professionals and patients that proton pump inhibitors (PPIs) may increase the risk of fractures of the hip, wrist and spine. The drugs' labeling will be revised to reflect these concerns. PPIs are used to reduce gastric...

Defibtech is recalling certain battery packs used in Lifeline and ReviveR automatic external defibrillators (AED). These battery packs may cause the AED to inappropriately cancel the charge and be unable to deliver therapy. The company has received...

FDA now has more information on the counterfeiting of Bard flat polypropylene surgical mesh, commonly known as Marlex mesh. This was first reported earlier this year. The counterfeit products, which were distributed between October 21, 2008 and Octo...

GlaxoSmithKline is warning healthcare professionals about the risk of thrombosis if patients with chronic liver disease are treated with Promacta (eltrombopag). Promacta is approved to treat thrombocytopenia in certain adult patients with chronic id...

The labeling for the weight loss drug orlistat will include new safety information about rare cases of severe liver injury in patients taking this drug. Orlistat is sold by prescription as Xenical in 120 mg strength and over the counter as Alli in 6...

The Institute for Safe Medication Practices (ISMP) recently pointed out that measuring doses with certain oral syringes can be confusing for healthcare practitioners and patients, and that this can lead to overdoses. This type of syringe is pack...

An important FDA program called "MedWatch" allows health care professionals and consumers to report serious problems that they believe may be associated with the medical products they prescribe, dispense, or use. These reports, along with follow-up i...

FDA monitors the way drug companies advertise and promote prescription drugs to help assure that the information is accurate and balanced. But it is difficult for the agency to check on these activities when they take place in doctors' offices, or i...

ChrisHartman: Afluria (CSL Ltd.) Influenza Virus Vaccine: Label Change - Risk of Fever and Febrile Seizure http://bit.ly/d7kCeM

Increased incidence of fever and febrile seizure among young children reported in Australia, mainly among those less than 5 years of age.

ChrisHartman: Miracle Mineral Solution (MMS): Product as consumed produces a potent bleach http://bit.ly/a8drOD

Product sold online as a dietary supplement. When consumed as instructed, produces an industrial bleach that can cause serious harm to health.

ChrisHartman: Nutraloid Labs ejaculoid XXTREME and stimuloid II: Undeclared Drug Ingredient http://bit.ly/9t5pB8

These products, marketed as dietary supplements, contain sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerously low levels.

ChrisHartman: Evamist (estradiol transdermal spray): Drug Safety Communication - Unintended Exposure of Children and Pets to .. http://bit.ly/994GuR

Reports of adverse effects in children who may have been unintentionally exposed to the drug through skin contact with women using this product.

ChrisHartman: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia http://bit.ly/ceoSHe